Waystar Holding Corp. (WAY) is a publicly traded company in the Healthcare — Medical - Healthcare Information Services industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting.
Is Waystar Holding Corp. stock overvalued or undervalued in 2026?
Waystar Holding Corp. (WAY) trades at 41.2× earnings (P/E), above the median of the 246 healthcare companies over $2bn in Kaplio's universe. At its sector median (30.4×) $21 (-26 %).
Kaplio overview: Waystar Holding Corp.
Market cap $6B · 52 weeks $17 – $40 (29 % below the high) · P/E 41.2× · 2027 expected P/E 15.3× · Dividend none · Next earnings November 2, 2026 · expected EPS $0.41 · Closing price, Oct 29 · accounts published Jul 29.
- Valuation: P/E 41.2× (expensive).
- Business: ROIC 3 % (weak).
- Balance sheet: Net debt/EBITDA 3.7× (fragile).
- Earnings: 6 of 8 (on track).
What would it be worth at its usual multiples?
At its sector median (30.4×) $21 (-26 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
What matters in pharma: 1 of 5 pass
- R&D / Revenue 5.0 %, fails.
- ROIC 3.4 %, fails.
- Net debt / EBITDA 3.7×, fails.
- Gross margin 68.3 %, borderline.
- FCF / Net Income 252.6 %, passes.
Against its peers (reference peers) — Waystar Holding Corp.: P/E 41.2×; EV/EBITDA 15.9×; ROIC 3.4 %; $5.5B. Doximity, Inc. (P/E 39.6×; EV/EBITDA 24.1×; ROIC 15.3 %; $6.0B), HealthEquity, Inc. (P/E 36.5×; EV/EBITDA 18.4×; ROIC 8.6 %; $8.4B), Hinge Health, Inc. (P/E 90.9×; EV/EBITDA 87.1×; ROIC 26.3 %; $9.4B).
Profitability
| Return on Equity | 3.59% |
| Return on Invested Capital | 3.37% |
| Return on Assets | 2.30% |
| Gross Margin | 69.11% |
| Operating Margin | 22.87% |
| Net Margin | 11.18% |
Financial Health
| Debt / Equity | 0.37 |
| Current Ratio | 1.85 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 2.16 |
Price Performance
| 1 month | +11.33% |
| 3 months | +33.63% |
| Year-to-date | -13.86% |
| 1 year | -23.88% |
Related companies: HQY · DOCS · TEM · BTSG · HNGE · HTFL · PRVA
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of WAY: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks